Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Hydrogel-based Drug System Market, by Polymer Origin
1.4.2 North America Hydrogel-based Drug System Market, by Delivery Route
1.4.3 North America Hydrogel-based Drug System Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Hydrogel-based Drug Delivery System Market by Polymer Origin
3.1 North America Synthetic Market by Country
3.2 North America Natural Market by Country
3.3 North America Hybrid Market by Country
Chapter 4. North America Hydrogel-based Drug Delivery System Market by Delivery Route
4.1 North America Ocular Market by Country
4.2 North America Subcutaneous Market by Country
4.3 North America Oral Cavity Market by Country
4.4 North America Topical Market by Country
4.5 North America Other Delivery Routes Market by Country
Chapter 5. North America Hydrogel-based Drug Delivery System Market by Country
5.1 US Hydrogel-based Drug Delivery System Market
5.1.1 US Hydrogel-based Drug Delivery System Market by Polymer Origin
5.1.2 US Hydrogel-based Drug Delivery System Market by Delivery Route
5.2 Canada Hydrogel-based Drug Delivery System Market
5.2.1 Canada Hydrogel-based Drug Delivery System Market by Polymer Origin
5.2.2 Canada Hydrogel-based Drug Delivery System Market by Delivery Route
5.3 Mexico Hydrogel-based Drug Delivery System Market
5.3.1 Mexico Hydrogel-based Drug Delivery System Market by Polymer Origin
5.3.2 Mexico Hydrogel-based Drug Delivery System Market by Delivery Route
5.4 Rest of North America Hydrogel-based Drug Delivery System Market
5.4.1 Rest of North America Hydrogel-based Drug Delivery System Market by Polymer Origin
5.4.2 Rest of North America Hydrogel-based Drug Delivery System Market by Delivery Route
Chapter 6. Company Profiles
6.1 Johnson & Johnson
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental &Regional Analysis
6.1.4 Research & Development Expenses
6.2 Bausch Health Companies, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Product Launches and Product Expansions:
6.3 Medtronic PLC
6.3.1 Company overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.4 Galderma S.A.
6.4.1 Company Overview
6.4.2 Recent strategies and developments:
6.4.2.1 Partnerships, Collaborations, and Agreements:
6.4.2.2 Approvals & Trials:
6.5 Endo International PLC
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental Analysis
6.5.4 Research & Development Expenses
6.6 Ferring Holdings SA
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research and Development Expense
6.7 Akorn Operating Company LLC
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Approvals & Trials:
6.8 Tolmar Pharmaceuticals, Inc.
6.8.1 Company Overview
6.9 Blairex Laboratories, Inc.
6.9.1 Company Overview
6.10. Ocular Therapeutix, Inc.
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Research & Development Expenses
6.10.4 Recent strategies and developments:
6.10.4.1 Partnerships, Collaborations, and Agreements:
6.10.4.2 Approvals & Trials:
Unique Offerings 